Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Up 116.3% in October

Pharma Mar, S.A. (OTCMKTS:PHMMF) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 26,600 shares, a growth of 116.3% from the October 15th total of 12,300 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 266.0 days.

Wall Street Analyst Weigh In

Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Price Performance

OTCMKTS PHMMF opened at $75.00 on Friday. The stock has a fifty day moving average of $60.04 and a 200-day moving average of $42.61. Pharma Mar has a 52 week low of $26.85 and a 52 week high of $75.00. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.